Deira Trading Company


Biogen stock was headed higher Wednesday, to bounce off an 11-year closing low, after the biotechnology company received positive news from regulators about its treatment for kidney-transplant rejections.

Leave a Reply

Your email address will not be published. Required fields are marked *

Source: CurrencyRate